RNA splicing and cancer

E Wang, I Aifantis - Trends in cancer, 2020 - cell.com
RNA splicing is an essential process that governs many aspects of cellular proliferation,
survival, and differentiation. Considering the importance of RNA splicing in gene regulation …

Alternative splicing and cancer: insights, opportunities, and challenges from an expanding view of the transcriptome

S Cherry, KW Lynch - Genes & Development, 2020 - genesdev.cshlp.org
Over the past decade there has been increased awareness of the potential role of
alternative splicing in the etiology of cancer. In particular, advances in RNA-Sequencing …

Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines

G Nishiguchi, LG Mascibroda, SM Young… - Nature …, 2024 - nature.com
Molecular-glue degraders are small molecules that induce a specific interaction between an
E3 ligase and a target protein, resulting in the target proteolysis. The discovery of molecular …

Genomic signatures of past and present chromosomal instability in Barrett's esophagus and early esophageal adenocarcinoma

C Bao, RW Tourdot, GJ Brunette, C Stewart… - Nature …, 2023 - nature.com
The progression of precancerous lesions to malignancy is often accompanied by increasing
complexity of chromosomal alterations but how these alterations arise is poorly understood …

Alternative splicing in cancer and immune cells

A Bernard, R Boidot, F Végran - Cancers, 2022 - mdpi.com
Simple Summary Alternative splicing is one of the most fabulous and important mechanism
in the cell. Alternative splicing is capable of generating many proteins from a single gene …

Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment

Y Chen, M Huang, X Liu, Y Huang, C Liu, J Zhu… - Cell Death & …, 2021 - nature.com
Alternative splicing (AS) is an important event that contributes to posttranscriptional gene
regulation. This process leads to several mature transcript variants with diverse …

Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 …

J Smeby, K Kryeziu, KCG Berg, IA Eilertsen, PW Eide… - …, 2020 - thelancet.com
Background PARP inhibitors are active in various tumour types beyond BRCA-mutant
cancers, but their activity and molecular correlates in colorectal cancer (CRC) are not well …

The role of alternative pre-mRNA splicing in cancer progression

S Choi, N Cho, EM Kim, KK Kim - Cancer Cell International, 2023 - Springer
Alternative pre-mRNA splicing is a critical mechanism that generates multiple mRNA from a
single gene, thereby increasing the diversity of the proteome. Recent research has …

Targeted splicing therapy: new strategies for colorectal cancer

Y Zheng, G Zhong, C He, M Li - Frontiers in Oncology, 2023 - frontiersin.org
RNA splicing is the process of forming mature mRNA, which is an essential phase
necessary for gene expression and controls many aspects of cell proliferation, survival, and …

Mapping alternative splicing events in colorectal cancer

Y Zheng, G Zhong, Q Song, H Zhang, S Wang, C Lin… - Discover Oncology, 2024 - Springer
Although aberrant splicing events of genes are closely related to the development and
progression of colorectal cancer (CRC), the mapping of abnormal splicing events, especially …